Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Overall Survival of Breast Cancer Patients With Locoregional Failures Involving Internal Mammary Nodes.

Xu AJ, DeSelm CJ, Ho AY, Gillespie EF, Braunstein LZ, Khan AJ, McCormick B, Powell SN, Cahlon O.

Adv Radiat Oncol. 2019 Mar 1;4(3):447-452. doi: 10.1016/j.adro.2019.02.004. eCollection 2019 Jul-Sep.

2.

Low-Dose Radiation Conditioning Enables CAR T Cells to Mitigate Antigen Escape.

DeSelm C, Palomba ML, Yahalom J, Hamieh M, Eyquem J, Rajasekhar VK, Sadelain M.

Mol Ther. 2018 Nov 7;26(11):2542-2552. doi: 10.1016/j.ymthe.2018.09.008. Epub 2018 Sep 13.

3.

A 3-Dimensional Mapping Analysis of Regional Nodal Recurrences in Breast Cancer.

DeSelm C, Yang TJ, Cahlon O, Tisnado J, Khan A, Gillespie E, Powell S, Ho A.

Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):583-591. doi: 10.1016/j.ijrobp.2018.10.021. Epub 2018 Oct 24.

PMID:
30367906
4.

Potential abscopal response to dual checkpoint blockade in RCC after reirradiation using dose-painting SBRT.

LaPlant Q, Deselm C, Lockney NA, Hsieh J, Yamada Y.

Pract Radiat Oncol. 2017 Nov - Dec;7(6):396-399. doi: 10.1016/j.prro.2017.04.009. Epub 2017 Apr 18. No abstract available.

PMID:
28551390
5.

CAR T-cell therapy for pancreatic cancer.

DeSelm CJ, Tano ZE, Varghese AM, Adusumilli PS.

J Surg Oncol. 2017 Jul;116(1):63-74. doi: 10.1002/jso.24627. Epub 2017 Mar 27. Review.

6.

Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.

Romesser PB, Cahlon O, Scher ED, Hug EB, Sine K, DeSelm C, Fox JL, Mah D, Garg MK, Han-Chih Chang J, Lee NY.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):386-95. doi: 10.1016/j.ijrobp.2016.02.036. Epub 2016 Feb 17.

7.

Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma.

Setton J, Han J, Kannarunimit D, Wuu YR, Rosenberg SA, DeSelm C, Wolden SL, Jillian Tsai C, McBride SM, Riaz N, Lee NY.

Oral Oncol. 2016 Feb;53:67-73. doi: 10.1016/j.oraloncology.2015.11.015. Epub 2015 Dec 7.

8.

Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy.

Kramer K, Pandit-Taskar N, Zanzonico P, Wolden SL, Humm JL, DeSelm C, Souweidane MM, Lewis JS, Cheung NK.

J Neurooncol. 2015 Jun;123(2):245-9. doi: 10.1007/s11060-015-1788-z. Epub 2015 May 6.

9.

AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake.

Rashmi R, DeSelm C, Helms C, Bowcock A, Rogers BE, Rader JL, Grigsby PW, Schwarz JK.

PLoS One. 2014 Apr 4;9(4):e92948. doi: 10.1371/journal.pone.0092948. eCollection 2014. Erratum in: PLoS One. 2014;9(9):e107846. Rader, Janet [corrected to Rader, Janet L].

10.

Paxillin contracts the osteoclast cytoskeleton.

Zou W, Deselm CJ, Broekelmann TJ, Mecham RP, Vande Pol S, Choi K, Teitelbaum SL.

J Bone Miner Res. 2012 Dec;27(12):2490-500. doi: 10.1002/jbmr.1706.

11.

Halofuginone prevents estrogen-deficient osteoporosis in mice.

Deselm CJ, Zou W, Teitelbaum SL.

J Cell Biochem. 2012 Oct;113(10):3086-92. doi: 10.1002/jcb.24185.

12.

IL-17 mediates estrogen-deficient osteoporosis in an Act1-dependent manner.

DeSelm CJ, Takahata Y, Warren J, Chappel JC, Khan T, Li X, Liu C, Choi Y, Kim YF, Zou W, Teitelbaum SL.

J Cell Biochem. 2012 Sep;113(9):2895-902. doi: 10.1002/jcb.24165.

13.

Autophagy proteins regulate the secretory component of osteoclastic bone resorption.

DeSelm CJ, Miller BC, Zou W, Beatty WL, van Meel E, Takahata Y, Klumperman J, Tooze SA, Teitelbaum SL, Virgin HW.

Dev Cell. 2011 Nov 15;21(5):966-74. doi: 10.1016/j.devcel.2011.08.016. Epub 2011 Nov 4. Erratum in: Dev Cell. 2011 Dec 13;21(6):1179.

14.

Fyn promotes proliferation, differentiation, survival and function of osteoclast lineage cells.

Kim HJ, Warren JT, Kim SY, Chappel JC, DeSelm CJ, Ross FP, Zou W, Teitelbaum SL.

J Cell Biochem. 2010 Dec 1;111(5):1107-13. doi: 10.1002/jcb.22841.

15.

Identification of Novel Myosin-V Binding Partners by Immunoprecipitation and Column Chromatography.

DeSelm CJ, Lu R, Cheney CM, Langford GM.

Biol Bull. 2004 Oct;207(2):164. No abstract available.

PMID:
27690614
16.

Rho-kinase is required for myosin-II-mediated vesicle transport during M-phase in extracts of clam oocytes.

W├Âllert T, DePina AS, DeSelm CJ, Langford GM.

Biol Bull. 2003 Oct;205(2):195-7. No abstract available.

PMID:
14583526
17.

Rab-GDI inhibits myosin V-dependent vesicle transport in squid giant axon.

DeSelm CJ, Brown JR, Lu R, Langford GM.

Biol Bull. 2003 Oct;205(2):190-1. No abstract available.

PMID:
14583523

Supplemental Content

Loading ...
Support Center